Pyridoxamine protects against mechanical defects in cardiac ageing in rats: Studies on load dependence of myocardial relaxation

Experimental Physiology

Volumn 99, Issue 11, 2014, Pages 1488-1498

  Wang, Chih Hsien ^a   Wu, En Ting ^a   Wu, Ming Shiou ^a   Tsai, Ming Shian ^b   Ko, Ya Hui ^c   Chang, Ru Wen ^c   Chang, Chun Yi ^a   Chang, Kuo Chu ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b E DA HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PYRIDOXAMINE; CARDIOTONIC AGENT; VITAMIN B COMPLEX;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; CIRCULATION; CONTROLLED STUDY; CROSS LINKING; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE RELAXATION; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART WEIGHT; MALE; MYOCARDIAL DISEASE; NONHUMAN; RAT; TREATMENT DURATION; ANIMAL; BODY WEIGHT; DRUG EFFECTS; FISCHER 344 RAT; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; ORGAN SIZE; PHYSIOLOGY; VASCULAR RESISTANCE;

AGING; ANIMALS; BODY WEIGHT; CARDIOTONIC AGENTS; MALE; MYOCARDIAL CONTRACTION; ORGAN SIZE; PYRIDOXAMINE; RATS; RATS, INBRED F344; STROKE VOLUME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT; VITAMIN B COMPLEX;

EID: 84939136514     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.082008     Document Type: Article

References (47)

1. Amarnath V, Amarnath K, Amarnath K, Davies S & Roberts LJ 2nd (2004). Pyridoxamine: an extremely potent scavenger of 1, 4-dicarbonyls. Chem Res Toxicol 17, 410-415.
2. Avendano GF, Agarwal RK, Bashey RI, Lyons MM, Soni BJ, Jyothirmayi GN & Regan TJ (1999). Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes 48, 1443-1447.
3. Barnea O & Jaron D (1990). A new method for the estimation of the left ventricular pressure-volume area. IEEE Trans Biomed Eng 37, 109-111.
4. Bernhard D & Laufer G (2008). The aging cardiomyocyte: a mini-review. Gerontology 54, 24-31.
5. Bidasee KR, Nallani K, Yu Y, Cocklin RR, Zhang Y, Wang M, Dincer UD & Besch HR Jr (2003). Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 52, 1825-1836.
6. 2+-ATPase. Diabetes 53, 463-473.
7. Booth AA, Khalifah RG, Todd P & Hudson BG (1997). In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J Biol Chem 272, 5430-5437.
8. Brutsaert DL & Sys SU (1989). Relaxation and diastole of the heart. Physiol Rev 69, 1228-1315.
9. Burgess ML, McCrea JC & Hedrick HL (2001). Age-associated changes in cardiac matrix and integrins. Mech Ageing Dev 122, 1739-1756.
10. Cain BS, Meldrum DR, Joo KS, Wang JF, Meng X, Cleveland JC Jr, Banerjee A & Harken AH (1998). Human SERCA2a levels correlate inversely with age in senescent human myocardium. J Am Coll Cardiol 32, 458-467.
11. Chang KC, Su MJ, Peng YI, Shao CC, Wu YC & Tseng YZ (2001). Mechanical effects of liriodenine on the left ventricular-arterial coupling in Wistar rats: pressure-stroke volume analysis. Br J Pharmacol 133, 29-36.
12. Gaasch WH, Blaustein AS, Andrias CW, Donahue RP & Avitall B (1980). Myocardial relaxation. II. Hemodynamic determinants of rate of left ventricular isovolumic pressure decline. Am J Physiol Heart Circ Physiol 239, H1-H6.
13. Gillebert TC & Lew WY (1991). Influence of systolic pressure profile on rate of left ventricular pressure fall. Am J Physiol Heart Circ Physiol 261, H805-H813.
14. Hori M, Inoue M, Kitakaze M, Tsujioka K, Ishida Y, Fukunami M, Nakajima S, Kitabatake A & Abe H (1985). Loading sequence is a major determinant of afterload-dependent relaxation in intact canine heart. Am J Physiol Heart Circ Physiol 249, H747-H754.
15. Isnard RN, Pannier BM, Laurent S, London GM, Diebold B & Safar ME (1989). Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coll Cardiol 13, 399-405.
16. Kangro T, Jonason T, Henriksen E & Ringqvist I (1997). Association of carotid arterial distensibility with Doppler indices of left ventricular filling in 50-year-old subjects. Clin Physiol 17, 579-590.
17. Karliner JS, LeWinter MM, Mahler F, Engler R & O'Rourke RA (1977). Pharmacologic and hemodynamic influences on the rate of isovolumic left ventricular relaxation in the normal conscious dog. J Clin Invest 60, 511-521.
18. Lakatta EG (1993). Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73, 413-467.
19. Lakatta EG & Levy D (2003a). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation 107, 139-146.
20. Lakatta EG & Levy D (2003b). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107, 346-354.
21. Latson TW, Yin FCP & Hunter WC (1987). The effects of finite wave velocity and discrete reflection on ventricular loading. In Ventricular/Vascular Coupling: Clinical, Physiological, and Engineering Aspects, ed. Yin FCP, pp. 354-383. Springer-Verlag, New York.
22. Laxminarayan S, Sipkema P & Westerhof N (1978). Characterization of the arterial system in the time domain. IEEE Trans Biomed Eng 25, 177-184.
23. Milnor WR (1989). Hemodynamics. Williams & Wilkins, Baltimore.
24. Murgo JP & Westerhof N (1987). Arterial reflections and pressure waveforms in humans. In Ventricular/Vascular Coupling: Clinical, Physiological, and Engineering Aspects, ed. Yin FCP, pp. 140-158. Springer-Verlag, New York.
25. Nagaraj RH, Sarkar P, Mally A, Biemel KM, Lederer MO & Padayatti PS (2002). Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch Biochem Biophys 402, 110-119.
26. Nichols WW, Avolio AP & Kelly RP (1993). Effects of age and of hypertension on wave travel and reflections. In Arterial Vasodilatation: Mechanisms and Therapy, ed. O'Rourke MF, Safar M & Dzau V, pp. 23-40. Edward Arnold, London.
27. Nichols WW & O'Rourke MF (2011). McDonald's Blood Flow in Arteries. Arnold, London.
28. Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T, Murgo JP & Pepine CJ (1985). Effects of age on ventricular-vascular coupling. Am J Cardiol 55, 1179-1184.
29. Noble MI (1968). The contribution of blood momentum to left ventricular ejection in the dog. Circ Res 23, 663-670.
30. Ohte N, Narita H, Hashimoto T, Akita S, Kurokawa K & Fujinami T (1998). Evaluation of left ventricular early diastolic performance by color tissue Doppler imaging of the mitral annulus. Am J Cardiol 82, 1414-1417.
31. O'Rourke MF (1990). Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 15, 339-347.
32. Rushmer RF, Crystal DK & Wagner C (1953). The functional anatomy of ventricular contraction. Circ Res 1, 162-170.
33. Safar ME, Toto-Moukouo JJ, Bouthier JA, Asmar RE, Levenson JA & Simon AC (1987). Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation 75, I156-I161.
34. Sagawa K (1981). The end-systolic pressure-volume relation of the ventricle: definition, modifications, and clinical use. Circulation 63, 1223-1227.
35. Shao CH, Capek HL, Patel KP, Wang M, Tang K, DeSouza C, Nagai R, Mayhan W, Periasamy M & Bidasee KR (2011). Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes. Diabetes 60, 947-959.
36. Sipkema P, Westerhof N & Randall OS (1980). The arterial system characterized in the time domain. Cardiovasc Res 14, 270-279.
37. Sunagawa K, Sagawa K & Maughan WL (1984). Ventricular interaction with the loading system. Ann Biomed Eng 12, 163-189.
38. Sunagawa K, Yamada A, Senda Y, Kikuchi Y, Nakamura M & Shibahara T (1980). Estimation of the hydromotive source pressure from ejection beats of the left ventricle. IEEE Trans Biomed Eng 27, 299-305.
39. Suga H, Sagawa K & Shoukas AA (1973). Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32, 314-322.
40. Takatori A, Ishii Y, Itagaki S, Kyuwa S & Yoshikawa Y (2004). Amelioration of the β-cell dysfunction in diabetic APA hamster by antioxidants and AGE inhibitor treatments. Diabetes Metab Res Rev 20, 211-218.
41. Takeuchi M, Igarashi Y, Tomimoto S, Odake M, Hayashi T & Tsukamoto T (1991). Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation 83, 202-212.
42. Voziyan PA, Metz TO, Baynes JW & Hudson BG (2002). A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 277, 3397-3403.
43. Weiss JL, Frederiksen JW & Weisfeldt ML (1976). Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58, 751-760.
44. Westerhof N, Sipkema P, van den Bos GC & Elzinga G (1972). Forward and backward waves in the arterial system. Cardiovasc Res 6, 648-656.
45. Wu ET, Liang JT, Wu MS & Chang KC (2011). Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation. Exp Gerontol 46, 482-488.
46. Wu MS, Chang CY, Chang RW & Chang KC (2012). Early return of augmented wave reflection impairs left ventricular relaxation in aged Fisher 344 rats. Exp Gerontol 47, 680-686.
47. Yamakado T, Takagi E, Okubo S, Imanaka-Yoshida K, Tarumi T & Nakamura M (1997). Effects of aging on left ventricular relaxation in humans: analysis of left ventricular isovolumic pressure decay. Circulation 95, 917-923.